Financials

Financials in One Page

Rajesh Exports is one of the world's largest gold conduits by turnover — FY2026 sales of ₹7,78,716 crore (≈$83 billion) pass through the books because the group owns Valcambi, the Swiss refinery. The flip side: operating margin is 0.014% and net margin is 0.014% — every ₹100 of revenue leaves ₹0.01 of profit. ROCE has collapsed from 18% (FY2015) to 2% (FY2026) while peer jewellery retailers earn 20–26%. The balance sheet looks superficially sturdy (gross debt only ₹1,016 cr against ₹17,269 cr equity), but FY2025–FY2026 saw a ₹10,505 cr swing into "Investments" matched by a ₹16,438 cr swing in "Other Liabilities" — capital is being parked in places the consolidated schedule does not disclose. Free cash flow is erratic across the cycle (₹+8,787 cr in FY2025 against negative FCF in five of the prior eight years). The market priced this in: P/B 0.17×, P/E ~26× on collapsing earnings, stock down ~82% over three years. The single financial metric that matters now is ROCE — without recovery toward the 9–11% mid-cycle level, the equity does not earn its cost of capital and the book value the discount rests on is not productive.

---

Revenue, Margins, and Earnings Power

Revenue is the wrong place to start with Rajesh Exports. The reported sales line is gross gold value moving through Valcambi and the Indian refining/manufacturing operations, not value added. A bullion bar bought, refined, and sold at a 0.3–0.5% conversion fee inflates the top line by the entire bullion value. That is why ₹7,78,716 cr of revenue produced only ₹107 cr of operating profit.

Revenue grew roughly 15× from FY2015 to FY2026, with a parabolic jump in FY2025–FY2026 as gold prices rallied and refining throughput stepped up. Growth here is not investor-relevant on its own because it scales with the gold price and the volume passed through, not with margin earned.

Profitability tells the real story. Operating profit peaked near ₹1,884 cr in FY2018 and has since deteriorated by 94% to ₹107 cr in FY2026. Net profit is now barely above ₹100 cr — less than the company earned in any single year FY2015–FY2023.

The margin curve is the underwriting case in one picture. Operating margin halved from 2.51% to 1.05% between FY2015 and FY2016 when the refining business scaled, then drifted lower for a decade, and collapsed under 0.5% from FY2024 onward. A pass-through business with near-zero margin earns no return on the capital it ties up — which is exactly what shows up later in the ROCE chart.

The quarterly profit line oscillates between small profits and small losses every two-to-three quarters, ending with a ₹54 cr loss in Q4 FY2026. There is no recovery trajectory yet — Q3 FY2026's ₹71 cr profit was given back the next quarter. Until the company prints two consecutive quarters of stable, positive operating profit, the earnings power is best assumed to be near zero.

---

Cash Flow and Earnings Quality

Free cash flow is what a business generates from operations after the capital spending needed to keep running. It is the truest test of whether reported profits are real. For Rajesh Exports, the answer is: rarely.

Look at the gap between net income (grey) and free cash flow (green). In FY2018, FY2021, FY2022, and FY2023 the company reported profits while burning cash — FY2021 alone burned ₹10,278 cr of FCF against ₹845 cr of "earnings". The cause is working capital: gold inventory, customer advances, and short-term lending swing wildly with bullion price and trade flows. Over 11 years (FY2015–FY2025), cumulative net income is ₹10,450 cr and cumulative FCF is ₹8,386 cr — an 80% blended conversion that masks four years when FCF was deeply negative despite positive earnings. The cushion is one single outsized year (FY2025 ₹+8,787 cr); strip it out and the remaining 10 years convert to a cumulative −₹401 cr of FCF.

The FY2025 spike (92×) is not quality — it reflects an unusual ₹7,738 cr release of working capital and a positive ₹1,049 cr capex line (i.e. FCF exceeded CFO, implying net proceeds from fixed-asset disposals or similar investing inflows). Strip out that one-off and the picture is of a company that cannot reliably turn an accounting profit into cash. The FY2026 cash-flow statement is not yet disclosed in the screener feed (data/financials/cash_flow.json shows null entries for FY2026).

Working capital swings dominate the cash picture. The cash conversion cycle ran negative through FY2020 (suppliers funded the business — typical of a strong refiner), then flipped positive FY2021–FY2024, and has since compressed back to 1 day. The shifts of tens of thousands of crores between Investments and Other Liabilities in FY2025–FY2026 (covered in the next section) are the dominant cash-flow events; profit-and-loss has almost nothing to say about whether the firm is generating value.

---

Balance Sheet and Financial Resilience

Headline leverage is tame: ₹1,016 cr of borrowings against ₹17,269 cr of book equity in FY2026 — a debt-to-equity of 0.06×. Cash + investments of ₹11,797 cr exceeds gross debt by a factor of more than ten. On the face of it, the balance sheet is fortress-class.

The stack shows the danger zone: Other Liabilities (the screener "Other Liabilities" line, which lumps trade payables, customer advances, gold-lease obligations, derivative payables and similar without segregation) ballooned from ₹6,170 cr (FY2024) to ₹22,608 cr (FY2026), a ₹16,438 cr expansion in two years. This dwarfs equity and is potentially the real leverage of the business, though the screener line does not allow underwriters to distinguish operating payables from finance-type obligations.

The cash conversion cycle measures how many days of sales are tied up in net working capital. From FY2015 through FY2020 it was negative — suppliers funded inventory, a sign of a strong refiner. Since FY2021 the cycle has been positive, meaning the firm has had to fund its own gold pipeline. By FY2026 it shrank back to 1 day, but only because receivables were squeezed to 3 days — an unusual reading for a company doing ₹7.8 lakh crore of throughput. Either Valcambi is settling cash on the day, or the trade pattern has shifted to upfront-paid bullion swaps. Worth questioning.

For a gold-conduit business, the balance sheet is the income statement. Leverage looks fine on the lender's view but the off-statement-of-profit movement of capital between Investments and Other Liabilities deserves a forensic eye that the standard screener-level schedules cannot satisfy.

---

Returns, Reinvestment, and Capital Allocation

Returns are the cleanest signal in the whole file. ROCE — operating profit divided by capital employed — measures whether a business earns more than the cost of the capital that runs it. Anything below the cost of capital (~10–12% in INR for a corporate of this profile) destroys value, regardless of how big revenue is.

ROCE walked down from 18–20% (FY2015–FY2016) to 9–11% (FY2020–FY2023) to 1–3% (FY2024–FY2026). The business stopped earning its cost of capital roughly three years ago, and it has not recovered. Peer jewellery retailers (Titan 25.8%, Kalyan 20.5%, Senco 20.9%, Goldiam 23.9%) earn five-to-twenty times this ROCE on the same gold-price tape.

Per the screener payout ratio history, dividend payout dropped to 0% from FY2023 onward and has stayed at zero for four reporting years. This is the largest capital-allocation signal in the dataset: when a business with ₹15,000+ cr of book equity stops returning anything to shareholders, the most common explanations are either an internal reinvestment opportunity or an inability to part with cash. Given that ROCE collapsed and the Investments line ballooned over the same period, the latter explanation deserves at least as much weight as the former.

Share count is unchanged at 30 crore shares since FY2015 (Equity Capital ₹300 cr at ₹1 face value, per balance_sheet.json) — no dilution, no buyback. EPS dropped from a peak ₹48.51 (FY2023) to ₹3.21 (FY2025) and ₹3.81 (FY2026) purely on operating earnings collapse, not financial-engineering.

Management has neither compounded per-share value nor returned excess cash. With dividends suspended, no buybacks, no segment growth disclosure, and capital piling into an opaque "Investments" line, the capital-allocation grade is at best ambiguous, at worst destructive.

---

Segment and Unit Economics

Segment and geography breakouts are not disclosed in the consolidated schedules available for this analysis (data/financials/segment.json returns an empty probe). The company reports a single line of revenue. From the annual-report metadata and public knowledge, Rajesh Exports operates two economically distinct businesses:

1. Refining (Valcambi SA, Switzerland) — multi-billion-dollar bullion throughput at low single-digit-bp conversion margin. This is the bulk of the revenue line.
2. Jewellery manufacturing and Shubh retail (India) — much smaller scale, structurally higher margin, but a fraction of the top line.

Without a segment cut, the analyst cannot tell which leg is dragging margins down, whether Shubh retail is profitable on its own, or whether Valcambi is earning the spread the FY2015–FY2020 history implied. This is itself a disclosure-quality flag — peers Titan, Kalyan, and Senco all publish segment cuts.

---

Valuation and Market Expectations

Choosing the right multiple matters more here than in most names. P/E is essentially meaningless when earnings are near zero — ₹112 cr of net profit on the trailing year gives a P/E of ~26×, but base earnings could double or halve next year on a 0.05% margin move. The cleaner gauges are price-to-book (which prices the gold-conduit balance sheet) and historical EV/EBITDA in normal years.

At ₹98.73 a share (NSE close, 2026-06-05) against derived book of ~₹576 per share (screener reports BV ₹585), the stock trades at 0.17× book — i.e. the market values the equity at less than one-fifth of stated book equity. That is consistent with two interpretations:

• Bull: book equity is real (Valcambi's refining asset, working bullion, Indian fixed assets) and the market is discounting it more than the fundamentals warrant.
• Bear: book equity is not real because the "Investments" line and inter-corporate-deposit-shaped balances may be impaired in ways the screener-level schedules do not reveal, and the market discount is appropriate.

The stock has lost roughly 90% from the all-time high of ₹1,029.7 (Feb 2023) to ₹98.73 today. Over three years (June 2023 → June 2026) the loss is ~82%; over one year ~51%. The chart of price tracks the chart of ROCE almost step-for-step.

Illustrative bear / base / bull range at a one-year horizon — these are scenario anchors, not point forecasts:

The current price (~₹98.73) sits within ~₹2 of the illustrative base case, meaning the market is not paying for any specific catalyst either way. The bull case requires the firm to demonstrate it can earn even mid-single-digit ROCE on the existing equity, plus clarity on what the ₹11,797 cr "Investments" line actually represents.

---

Peer Financial Comparison

The peer table is unkind. Rajesh Exports has nearly 9× the revenue of Titan but under 1% of the market cap (₹2,962 cr vs ₹3,75,969 cr — about 0.79%), because every other gold/jewellery comp earns 7–21% operating margin and 10–26% ROCE while Rajesh earns 0.014% margin and ~2% ROCE. The closest near-distressed analog is PC Jeweller — a previously distressed listed exporter — which now earns ROCE of ~9.58% on book and trades at ~0.98× book. Rajesh trades at less than a fifth of that book multiple, which positions the equity closer to "going-concern-uncertain" than to "down-cycle compounder". Goldiam, the closest model-fit peer (jewellery-export manufacturer), earns ~21% margins and ~23.9% ROCE — i.e. the same business archetype done well.

No peer in this set has dropped its dividend to zero for four straight years. None has the same magnitude of unexplained Investments expansion. None has trailing three-year share-price losses approaching 80%+. The peer comparison suggests the discount is earned, not accidental.

---

What to Watch in the Financials

What the financials confirm. Revenue scale is real (it is one of the world's largest gold conduits). The discount to book is the cleanest market signal there is — at 0.17× P/B against peers at 1–24×, the market is not arguing about growth, it is arguing about whether the book is collectable.

What the financials contradict. The bullish "valuation discount = opportunity" framing has to confront ROCE that has been sub-cost-of-capital for three to four years, dividend payout reported at 0% for four reporting years, a ~₹10,505 cr Investments build-up matched by a ~₹16,438 cr Other-Liabilities expansion that the screener schedules do not break out, and a CFO/PnL relationship that has been erratic for a decade. The discount appears to be the market doing the work that the publicly available financial schedules cannot.

The first financial metric to watch is ROCE. Without a structural recovery toward the 9–11% mid-cycle level — driven by either margin normalisation in refining or contraction of unproductive "Investments" — the equity is not earning the capital it ties up, and the P/B 0.17× could persist as a value trap. Watch the FY2027 H1 disclosure: if ROCE prints above 4% with positive operating margin and the Investments line is held flat or reduced, the bull case opens; if not, the discount may remain durable.